<!DOCTYPE html>
<html lang="en">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Case Study: Tengu Muna - Global NSCLC Trial Management</title>
    <script src="https://cdn.tailwindcss.com"></script>
    <link rel="preconnect" href="https://fonts.googleapis.com">
    <link rel="preconnect" href="https://fonts.gstatic.com" crossorigin>
    <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700&display=swap" rel="stylesheet">
    <style>
        body {
            font-family: 'Inter', sans-serif;
        }
        .gradient-bg {
            background: linear-gradient(135deg, #f5f7fa 0%, #c3cfe2 100%);
        }
        .card {
            background: white;
            border-radius: 0.75rem;
            box-shadow: 0 10px 15px -3px rgba(0, 0, 0, 0.1), 0 4px 6px -2px rgba(0, 0, 0, 0.05);
            transition: transform 0.3s ease, box-shadow 0.3s ease;
        }
        .card:hover {
            transform: translateY(-5px);
            box-shadow: 0 20px 25px -5px rgba(0, 0, 0, 0.1), 0 10px 10px -5px rgba(0, 0, 0, 0.04);
        }
        .icon {
            width: 3rem;
            height: 3rem;
        }
        .tag {
            display: inline-block;
            background-color: #e0e7ff;
            color: #4338ca;
            padding: 0.25rem 0.75rem;
            border-radius: 9999px;
            font-size: 0.875rem;
            font-weight: 500;
            margin: 0.25rem;
        }
    </style>
</head>
<body class="gradient-bg text-slate-800">

    <!-- Header Section -->
    <header class="bg-white/80 backdrop-blur-sm shadow-md sticky top-0 z-50">
        <div class="container mx-auto px-6 py-4">
            <div class="text-center">
                <h1 class="text-2xl md:text-3xl font-bold text-slate-900">Tengu Muna</h1>
                <p class="text-md md:text-lg text-indigo-600 font-medium">Global Studies Manager / Global Clinical Trial Manager</p>
            </div>
        </div>
    </header>

    <!-- Main Content -->
    <main class="container mx-auto px-6 py-12">

        <!-- Case Study Title -->
        <section class="text-center mb-16">
            <h2 class="text-3xl md:text-5xl font-extrabold text-slate-900 leading-tight">
                Case Study: Strategic Management of a Complex Global NSCLC Trial
            </h2>
            <p class="mt-4 text-lg md:text-xl text-slate-600 max-w-3xl mx-auto">
                Navigating Companion Diagnostics, Global Startup Hurdles, and Health Equity Integration with Masterful Precision.
            </p>
        </section>

        <!-- Key Challenges Section -->
        <section class="mb-16">
            <div class="card p-8">
                <div class="flex items-center mb-6">
                    <div class="bg-red-100 p-3 rounded-full mr-4">
                        <svg class="icon text-red-600" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M13 16h-1v-4h-1m1-4h.01M21 12a9 9 0 11-18 0 9 9 0 0118 0z"></path></svg>
                    </div>
                    <h3 class="text-2xl font-bold text-slate-900">Key Challenges</h3>
                </div>
                <p class="mb-6 text-slate-600">This global NSCLC trial involved a PD-L1 companion diagnostic and exploratory biomarkers (EGFR, ROS1, TROP2), presenting a confluence of critical operational hurdles:</p>
                <ul class="space-y-4 text-slate-700">
                    <li class="flex items-start"><span class="text-red-500 mr-3 mt-1">&#10148;</span><strong>Regulatory Delays:</strong> Significant EUCTR and IVDR approval hurdles, especially for qualifying the PD-L1 testing lab in Scotland.</li>
                    <li class="flex items-start"><span class="text-red-500 mr-3 mt-1">&#10148;</span><strong>Startup Bottlenecks:</strong> Complex startup processes across Europe and South America requiring dynamic site selection and tiering.</li>
                    <li class="flex items-start"><span class="text-red-500 mr-3 mt-1">&#10148;</span><strong>Logistical Gaps:</strong> Inconsistent lab capabilities for exploratory biomarkers necessitating central lab support.</li>
                    <li class="flex items-start"><span class="text-red-500 mr-3 mt-1">&#10148;</span><strong>Recruitment & DEI:</strong> Widespread recruitment difficulties coupled with the mandate for robust DEI integration in North America.</li>
                    <li class="flex items-start"><span class="text-red-500 mr-3 mt-1">&#10148;</span><strong>Data Integrity:</strong> Immense pressure to ensure data quality for an upcoming futility analysis amid competing regional timelines.</li>
                </ul>
            </div>
        </section>

        <!-- Strategic Solutions Grid -->
        <section class="grid md:grid-cols-2 lg:grid-cols-3 gap-8 mb-16">

            <!-- Card 1: Study Startup -->
            <div class="card p-6">
                <h4 class="text-xl font-bold mb-3 text-indigo-700">1. Dynamic Study Startup in Europe</h4>
                <p class="text-slate-600 mb-4">Aggressively mitigated EUCTR & IVDR delays through a hands-on, data-driven strategy.</p>
                <div class="space-y-1">
                    <span class="tag">Week-by-Week Tracking</span>
                    <span class="tag">Site Tiering</span>
                    <span class="tag">RFI Management</span>
                    <span class="tag">Country Lead Coordination</span>
                </div>
            </div>

            <!-- Card 2: DEI & DCT -->
            <div class="card p-6">
                <h4 class="text-xl font-bold mb-3 text-indigo-700">2. DEI & Decentralized Trials (DCT)</h4>
                <p class="text-slate-600 mb-4">Embedded equity into the trial's fabric and reduced patient burden in North America.</p>
                <div class="space-y-1">
                    <span class="tag">Community Partnerships</span>
                    <span class="tag">Inclusive Recruitment</span>
                    <span class="tag">Telemedicine</span>
                    <span class="tag">Remote Monitoring</span>
                </div>
            </div>

            <!-- Card 3: Enrollment -->
            <div class="card p-6">
                <h4 class="text-xl font-bold mb-3 text-indigo-700">3. Cross-Regional Enrollment</h4>
                <p class="text-slate-600 mb-4">Managed competing timelines between rapidly enrolling APAC and slower EU/American regions.</p>
                <div class="space-y-1">
                    <span class="tag">Region-Specific Targets</span>
                    <span class="tag">Dynamic Re-forecasting</span>
                    <span class="tag">Agile Strategy</span>
                </div>
            </div>

            <!-- Card 4: Biomarker Testing -->
            <div class="card p-6">
                <h4 class="text-xl font-bold mb-3 text-indigo-700">4. Biomarker & Lab Management</h4>
                <p class="text-slate-600 mb-4">Ensured testing integrity for the critical PD-L1 CDx and exploratory biomarkers.</p>
                <div class="space-y-1">
                    <span class="tag">Central Lab Oversight</span>
                    <span class="tag">IVDR Compliance</span>
                    <span class="tag">Dedicated Workflow Team</span>
                </div>
            </div>

            <!-- Card 5: PI Engagement -->
            <div class="card p-6">
                <h4 class="text-xl font-bold mb-3 text-indigo-700">5. PI Engagement & Recruitment</h4>
                <p class="text-slate-600 mb-4">Re-energized disengaged sites and filled recruitment gaps across Europe and South America.</p>
                <div class="space-y-1">
                    <span class="tag">MSL Collaboration</span>
                    <span class="tag">Performance Dashboards</span>
                    <span class="tag">Targeted Outreach</span>
                </div>
            </div>

            <!-- Card 6: Monitoring -->
            <div class="card p-6">
                <h4 class="text-xl font-bold mb-3 text-indigo-700">6. Monitoring & Data Integrity</h4>
                <p class="text-slate-600 mb-4">Maintained data quality under pressure for the critical futility analysis decision point.</p>
                <div class="space-y-1">
                    <span class="tag">Real-Time Dashboards</span>
                    <span class="tag">Futility Analysis Readiness</span>
                    <span class="tag">Data Management Coordination</span>
                </div>
            </div>

        </section>

        <!-- Conclusion Section -->
        <section>
            <div class="card p-8 bg-slate-800 text-white">

                <div class="flex items-center mb-6">
                    <div class="bg-green-100 p-3 rounded-full mr-4">
                        <svg class="icon text-green-600" fill="none" stroke="currentColor" viewBox="0 0 24 24" xmlns="http://www.w3.org/2000/svg"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path></svg>
                    </div>
                    <h3 class="text-2xl font-bold text-white">Conclusion</h3>
                </div>
                <p class="text-lg text-slate-300">
                    This trial demonstrated the operational complexity of managing a global NSCLC program with a PD-L1 companion diagnostic under EUCTR and IVDR regulations. By implementing a dynamic study startup model, maintaining tight lab oversight, integrating DEI strategies, and leveraging decentralized trial tools, we ensured regulatory compliance, improved patient access, and maintained momentum despite multi-regional startup delays.
                </p>
            </div>
        </section>
    </main>

    <!-- Footer -->
    <footer class="mt-16 py-8 bg-white/50">
        <div class="container mx-auto px-6 text-center">
            <p class="text-slate-600 font-medium">This case study was developed by Tengu Muna.</p>
            <p class="text-sm text-slate-500">Consulting Global Studies Manager / Global Clinical Trial Manager</p>
        </div>
    </footer>

</body>
</html>
